Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,460 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Bright Uro, Inc.Biotechnology
Irvine, California · founded 2021 · Equity · 35 investors · Michael Frazzette, Kevin Hershberger
Bright Uro, Inc.Biotechnology
Irvine, California · founded 2021 · Equity · 29 investors · Michael Frazzette, Derek Herrera
Angiocrine Bioscience, Inc.Biotechnology
San Diego, California · Equity · 16 investors · David Parkinson, Jeffrey Port
Dev4 LLCBiotechnology
Houston, Texas · founded 2023 · Equity · 27 investors · Arnold-Peter Weiss, Lance Terrill
TopoDx, Inc.Biotechnology
Atlanta, Georgia · founded 2024 · Equity · 10 investors · Peter Yunker, David Weiss
TopoDx, Inc.Biotechnology
Atlanta, Georgia · founded 2024 · Equity · 6 investors · David Weiss, Yogi Patel
Surebion, Inc.Biotechnology
Los Angeles, California · founded 2025 · Equity · 5 investors · Susanne Nichalas, Stephen Rothman
Treeline Biosciences, Inc.Biotechnology
Watertown, Massachusetts · founded 2021 · Equity, Options · 22 investors · Steven Elms, Kristina Burow
PharmaCyte Biotech, Inc.Biotechnology
Las Vegas, Nevada · Equity, Options · 12 investors · Robert Weinstein, Jonathan Schechter
Enhanced Fusion Technologies L.L.C.Biotechnology
Vienna, Virginia · founded 2024 · Equity · 6 investors · Timothy Murphy
Circula-AI IncBiotechnology
Boca Raton, Florida · Debt, Options · 7 investors · Albert Hummel, Brock Smith
Potrero Medical, Inc.Biotechnology
Hayward, California · Equity · 29 investors · Maurice Ferre, Ramachandra Reddy
Oncobiomix Inc.Biotechnology
San Antonio, Texas · founded 2023 · Convertible Debt · 12 investors · Michael Liss
Oncobiomix Inc.Biotechnology
San Antonio, Texas · founded 2023 · Convertible Debt · 12 investors · Michael Liss
Oncobiomix Inc.Biotechnology
San Antonio, Texas · founded 2023 · Convertible Debt · 12 investors · Michael Liss
Petal Surgical, Inc.Biotechnology
Redwood City, California · founded 2021 · Equity, Debt · 40 investors · Frederic Moll, Prashant Chopra
TM Holding Companies, Inc.Biotechnology
Memphis, Tennessee · founded 2025 · Equity · 78 investors · Sheryl Moroschak, Dennis Long
Cadenza Bio, Inc.Biotechnology
Yukon, Oklahoma · founded 2022 · Debt · 10 investors · Elaine Hamm, Tom Denison
SISCAPA Assay Technologies, Inc.Biotechnology
Washington, District Of Columbia · Equity · 1 investors · Constance Seniff, Terry Pearson
Rudhira Biosciences, Inc.Biotechnology
Cary, North Carolina · founded 2025 · Debt, Options, Convertible · 3 investors · Vijaya Singamsetty
Xanadu Bio, Inc.Biotechnology
Gladwyne, Pennsylvania · founded 2021 · Equity, Series B Preferred Stock · 4 investors · Taylor Feehley, Mark Saltzman
Inversion Therapeutics, Inc.Biotechnology
Burlingame, California · founded 2024 · Equity · 4 investors · Samad Wahid, M.D., James Wells, Ph.D.
Absco Therapeutics, Inc.Biotechnology
Allston, Massachusetts · founded 2024 · Debt, Convertible · 1 investors · Stephen Linderman, Carlo Giovanni Traverso
Promptus LLCBiotechnology
Greenwood Village, Colorado · founded 2025 · Debt, Convertible Promissory Note · 1 investors · Patrick McCain, Gary Graham
Gameto, Inc.Biotechnology
Bee Cave, Texas · Equity · 22 investors · Martin Varsavsky, Dina Radenkovic
Superluminal Medicines, Inc.Biotechnology
Boston, Massachusetts · founded 2023 · Debt, Convertible promissory note and the securities issuable upon conversion th · 1 investors · Dylan Morris, Andrew Levin
X4 Pharmaceuticals, IncBiotechnology
Boston, Massachusetts · Equity, Options, Convertible · 18 investors · Mary DiBiase, Murray Stewart
Plexium, Inc.Biotechnology
San Diego, California · Equity · 20 investors · Serge Messerlian, Cariad Chester
Cascade Biocatalysts, Inc.Biotechnology
Denver, Colorado · founded 2022 · Equity · 41 investors · Alexander Rosay, James Weltz
Linnaeus Therapeutics, Inc.Biotechnology
Haddonfield, New Jersey · Debt, Convertible · 3 investors · James Demetriades, Jack Lepping